Brief: Island Pharmaceuticals Says GMP Manufacturing Of Galidesivir Commenced
04/06/2026 24:22
BRIEF-Island Pharmaceuticals Says GMP Manufacturing Of Galidesivir Commenced June 4 (Reuters) - Island Pharmaceuticals Ltd ILA.AX:
GMP MANUFACTURING OF GALIDESIVIR COMMENCED TO SUPPORT PIVOTAL MARBURG STUDY UNDER US FDA'S ANIMAL RULE PATHWAY
EXECUTED AGREEMENT WITH PI HEALTH SCIENCES
Further company coverage: ILA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says FDA Grants Orphan Designation For Galidesivir In Marburg
Australia's Island Pharmaceuticals rises on agreement extension with US Army
Brief: Island Pharmaceuticals Says GMP Manufacturing Of Galidesivir Commenced
Australia's Island Pharmaceuticals rises on US government collaboration
Brief: Island Pharmaceuticals Seeks Trading Halt